Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Recruitment challenges due to COVID-19 pandemic
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to determine if a hospital-based antenatal yoga program (HB-AYP) is a feasible, acceptable and potentially efficacious intervention for women with antenatal anxiety and/or depression?
Anxiety and depression are the most common psychological symptoms reported in pregnant women and can result in adverse obstetric, neonatal and post-partum mental health outcomes. Although there is a range of effective first-line treatments for anxiety and depression, these treatments are not without limitations. Concerns about the safety of antidepressant medication during pregnancy, lack of access to affordable psychosocial treatments and reluctance to seek mental health care due to stigma may prevent pregnant women from receiving optimal care for their symptoms. Recently, there has been growing interest in alternative and complementary approaches to manage anxiety and depression. These approaches may offer women with antenatal anxiety and depression an alternative treatment option that may be more acceptable and perceived as more holistic and less stigmatizing than conventional mental health care. One way to optimize access to yoga therapy during prenatal care is to implement an antenatal yoga program within a public healthcare system. Accordingly, the overarching aim of this study is to evaluate the feasibility of a hospital-based antenatal yoga program (HB-AYP) plus treatment as usual for anxiety and depression, and obtain preliminary data on its potential efficacy relative to treatment as usual plus biweekly clinical monitoring(TAU) This pilot research will provide much needed preliminary data that will set the foundation for designing a fully-powered prospective randomized controlled trial (RCT) of a HB-AYP. In the long term, it is hoped that this line of research will influence evidence-based clinical guidelines for managing antenatal anxiety and depression and service delivery.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Yoga intervention plus TAU | Experimental | Participants randomized to the yoga intervention will attend 8-weekly 90-minute group sessions. The intervention will be delivered by certified instructors with experience facilitating yoga classes for pregnant women. Monthly "drop-in" classes will be scheduled in order to motivate women to maintain their practice during the follow-up period. The yoga intervention will be based on the hatha yoga system modified for pregnancy. TAU will include treatment based on the recommendation of participants' healthcare provider/team. |
|
| Clinical Monitoring plus TAU | Other | Clinical monitoring will be conducted by telephone and include a 15-20 minutes discussions of how the participant has been feeling over the past two weeks. A standard format will be used for conducting the clinical monitoring telephone calls. TAU will include treatment based on the recommendation of participants' healthcare provider/team. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Yoga intervention plus TAU | Other | The yoga intervention consists of 8 weekly group sessions. The intervention is based on hatha yoga system. TAU is usual care participants receive from their health care provider |
| Measure | Description | Time Frame |
|---|---|---|
| Edinburgh Postnatal Depression Scale | measure of depressive symptoms | Baseline; week 4; week 8; bimonthly until 6 months postpartium |
| Measure | Description | Time Frame |
|---|---|---|
| Perceived Stress Scale | measure of stress | Baseline; Week 8; bimonthly until 6-months postpartum; |
| Interpersonal Relationships Inventory (interpersonal support subscale) | Measure of interpersonal support |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility outcomes | Ease of recruitment; study compliance, program satisfaction; perception of treatment credibility | Week 1 to 8 |
| Pregnancy outcomes | Presence of gestational diabetes and hypertension; gestational age at delivery, mode of delivery, pregnancy and birth complications, infant birth weight; Apgar scores |
Inclusion Criteria: Healthy women in their second trimester of an uncomplicated pregnancy with elevated levels of anxiety and/or depression (based on the PHQ-9 and GAD-7) will be eligible to participate
-
Exclusion Criteria: i) a lifetime history of psychosis, ii) symptoms of mania/hypomania in the past 12 months; iii) a history of substance use disorders in the last 6 months; iv) a history of self-harm in the last 6 months; v) high suicide risk; vi) engaged in a regular formal meditative practice at least once a month over the past 12 months; and vii) yoga postures are contraindicated.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Diana Koszycki, PhD | Institut du Savoir Montfort | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Participants will be randomly assigned to the yoga intervention plus treatment as usual (TAU) or TAU plus biweekly clinical monitoring
Not provided
Not provided
The MINI will be administered at 6-months post-partum by a blind assessor
| Clinical Monitoring plus TAU | Other | clinical monitoring includes bi-weekly 15-20 minute telephone contact with participants. TAU is usual care participants receive from their health care provider. |
|
| Baseline; Week 8; 6-months post-partum |
| Dyadic Adjustment Scale | Measure of marital adjustment | Baseline; Week 8; 6-months post-partum |
| Five Facet Mindfulness Scale | Measure of facets of mindfulness | Baseline; Week 8; 6-months post-partum |
| Self-Compassion Scale | Measure of self-compassion | Baseline; Week 8; 6-months post-partum |
| Prenatal Attachment Inventory | Measure of prenatal attachment | Baseline; Week 8 |
| Post-partum bonding questionnaire | Measure of post-partum bonding | 6-months postpartum |
| Baseline and week 8 and post-partum |
| Stress hormones | Salivary cortisol and alpha amylase | Baseline and week 8 for mother and 8-weeks and 6-months for infant |